CFDB - Cystic Fibrosis DataBase

ongoing trials trial from

A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF - Phase 2 - Not yet recruiting

Study design (if review, criteria of inclusion for studies)

Interventional - Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment


Cystic Fibrosis - 12 Years and older   (Child, Adult, Older Adult)


Drug: Anakinra

Outcome measures

Absolute pre-post change of the lung clearance index (LCI)

Keywords: Anakinra; Anti-Inflammatory Agents; pharmacological_intervention;